In vitro activity of grepafloxacin and 25 other antimicrobial agents against Streptococcus pneumoniae: correlation

C Thornsberry1, P T Ogilvie, H P Holley

  • 1MRL Pharmaceutical Services, Brentwood, Tennessee 37027, USA.

Clinical Therapeutics
|January 23, 1999
PubMed

Insights

Penicillin resistance in Streptococcus pneumoniae strains correlates with resistance to many antibiotics, but not fluoroquinolones, rifampin, or vancomycin. This guides empiric therapy selection for pneumococcal infections.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Pharmacology

Background:

  • Streptococcus pneumoniae is a leading cause of bacterial infections.
  • Antimicrobial resistance in S. pneumoniae poses a significant public health challenge.
  • Understanding resistance patterns is crucial for effective treatment.

Purpose of the Study:

  • To evaluate the in vitro susceptibility of S. pneumoniae strains to various antimicrobial agents.
  • To determine the correlation between penicillin resistance and resistance to other drug classes.
  • To inform empiric therapy choices for pneumococcal infections.

Main Methods:

  • Testing susceptibility of U.S. S. pneumoniae isolates (susceptible, intermediate, high penicillin resistance) to 26 antimicrobial agents.
  • Classifying agents into penicillins, cephalosporins, macrolides, fluoroquinolones, etc.
  • Analyzing correlations between penicillin resistance and resistance to other agents.

Main Results:

  • Penicillin and macrolide activities were similar; cephalosporin and fluoroquinolone activities varied.
  • Fluoroquinolone activity order: grepafloxacin > sparfloxacin > levofloxacin > ciprofloxacin > ofloxacin.
  • Penicillin resistance correlated with resistance to penicillins, cephalosporins, macrolides, clindamycin, tetracycline, and trimethoprim-sulfamethoxazole.

Conclusions:

  • Penicillin resistance in S. pneumoniae is linked to resistance to several key antibiotic classes.
  • Resistance to fluoroquinolones, rifampin, and vancomycin did not correlate with penicillin resistance.
  • Findings aid clinicians in selecting appropriate empiric treatment for S. pneumoniae infections.

Related Concept Videos

Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...